Membrane protein damage and methylation reactions in chronic renal failure

Kidney International

Volumn 50, Issue 2, 1996, Pages 358-366

  Perna, Alessandra F ^a,b   Ingrosso, Diego ^a   Galletti, Patrizia ^a   Zappia, Vincenzo ^a   De Santo, Natale G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; MEMBRANE PROTEIN; S ADENOSYLMETHIONINE;

AMINO ACID METABOLISM; CELL COMPOSITION; CHRONIC KIDNEY FAILURE; ERYTHROCYTE MEMBRANE; HUMAN; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN PROCESSING; REVIEW;

EID: 0029788271     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.324     Document Type: Editorial

References (94)

1. GALLETTI P, INGROSSO D, MANNA C, CLEMENTE G, ZAPPIA V: Protein damage and methylation mediated repair in the erythrocyte. Biochem J 306:313-325, 1995
2. OTA IM, CLARKE S: The function and enzymology of protein D-aspartyl/L-isoaspartyl methyltrasferases in eukaryotic and prokaryotic cells, in Protein Methylation, edited by PAIK WK, KIM S, Boca Raton, CRC Press, 1990, pp 179-194
3. JOHNSON BA, LANGMACK EL, ASWAD DW: Partial repair of deamidation-damaged calmodulin by protein carboxylmethyltransferase. J Biol Chem 262:12283-12287, 1987
4. OTA IM, CLARKE S: Multiple sites of methyl esterification of calmodulin in intact erythrocytes. Arch Biochem Biophys 279:320-327, 1990
5. OTA IM, CLARKE S: Calcium affects the spontaneous degradation of aspartyl/asparaginyl residues in calmodulin. Biochemistry 28:4020-4027, 1989
6. OTA IM, CLARKE S: Enzymatic methylation of L-isoaspartyl residues derived from aspartyl residues in affinity-purified calmodulin: The role of conformational flexibility in spontaneous isoaspartyl formation. J Biol Chem 264:54-60, 1989
7. ROHER AE, LOWENSON JD, CLARKE S, WOLKOW C, WANG R, COTTER RJ, REARDON IM, ZÜRCHER-NEELY HA, HEINRIKSON RL, BALL MJ, GREENBERG BD: Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J Biol Chem 268:3072-3083, 1993
8. ROHER AE, LOWENSON JD, CLARKE S, WOODS AS, COTTER RJ, GOWING E, BALL MJ: β-amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 90:10836-10840, 1993
9. FABIAN H, SZENDREI GI, MANTSCH HH, GREENBERG BD, ÖTVÖS L JR: Synthetic post-translationally modified human Aβ peptide exhibits a markedly increased tendency to form β-pleated sheets in vitro. Eur J Biochem 221:959-964, 1994
10. INGROSSO D, CLARKE S: Human erythrocyte D-aspartyl/L-isoaspartyl methyltransferase: Enzymes that recognize age-damaged proteins, in Red Blood Cell Aging, edited by MAGNANI M, DE FLORA A, New York, Plenum Press, 1991, p 263
11. BOIVIN D, GINGRAS D, BELIVEAU R: Purification and characterization of a membrane-bound protein carboxyl methyltransferase from rat kidney cortex. J Biol Chem 268:2610-2615, 1993
12. INGROSSO D, FOWLER AV, BLEIBAUM J, CLARKE S: Sequence of the D-aspartyl/L-isoaspartyl methyltransferase from human erythrocytes: Common sequence motifs for protein, DNA, RNA and small molecule S-adenosylmethionine-dependent methyltransferases. J Biol Chem 264:20131-20139, 1989
13. INGROSSO D, KAGAN RM, CLARKE S: Distinct C-terminal sequences of isozymes I and II of the human erythrocyte L-isoaspartyl/D-aspartyl protein methyltransferase. Biochem Biophys Res Commun 175:351-358, 1991
14. MACLAREN DC, KAGAN RM, CLARKE S: Alternative splicing of the human isoaspartyl protein carboxyl methyltransferase RNA leads to the generation of a C-terminal-RDEL sequence in isoenzyme II. Biochem Biophys Res Commun 185:277-283, 1992
15. OTA IM, GILBERT JM, CLARKE S: Two major isozymes of the protein D-aspartyl/L-isoaspartyl methyltransferase from human erythrocytes. Biochem Biophys Res Commun 151:1136-1139, 1988
16. GALLETTI P, CIARDIELLO A, INGROSSO D, DI DONATO A, D'ALESSIO G: Repair of isopeptide bonds by protein carboxyl O-methyltransferase: Seminal ribonuclease as a model system. Biochemistry 27:1752-1757, 1988
17. MCFADDEN PN, CLARKE S: Conversion of isoaspartyl peptides to normal peptides: Implications for the cellular repair of damaged proteins. Proc Natl Acad Sci USA 84:2595-2599, 1987
18. JOHNSON BA, MURRAY ED, CLARKE S, GLASS DB, ASWAD DW: Protein carboxyl methyltransferase facilitates conversion of atypical L-isoaspartyl peptides to normal L-aspartyl peptides. J Biol Chem 262:5622-5629, 1987
19. LOWENSON JD, CLARKE S: Spontaneous degradation and enzymatic repair of aspartyl and asparaginyl residues in aging red cell proteins analyzed by computer simulation. Gerontology 37:128-151, 1991
20. BRENNAN TV, ANDERSON JW, JIA Z, WAYGOOD EB, CLARKE S: Repair of spontaneously deamidated phosphocarrier protein catalyzed by the L-isoaspartate-(D-Aspartate) O-methyltransferase. J Biol Chem 269:24586-24595, 1994
21. ASWAD DW, JOHNSON BA, LANGMACK EL, SHIROKAWA JM: Modification of isoaspartyl peptides and proteins by protein carboxyl methyltransferase from bovine brain, in Advances in Post-translational Modifications of Proteins and Aging, edited by ZAPPIA V, GALLETTI P, PORTA R, WOLD F, New York, Plenum Press, 1988, pp 247-259
22. ODEN KL, CLARKE S: S-adenosyl-L-methionine synthetase from human erythrocytes: Role in the regulation of cellular S-adenosylmethionine levels. Biochemistry 22:2978-2986, 1983
23. INGROSSO D, D'ANGELO S, PERNA AF, IOLASCON A, MIRAGLIA DEL GIUDICE E, PERROTTA S, ZAPPIA V, GALLETTI P: Increased membrane protein methylation in hereditary spherocytosis: A marker of cytoskeletal disarray. Eur J Biochem 228:894-898, 1995
24. GALLETTI P, INGROSSO D, NAPPI A, GRAGNANIELLO V, IOLASCON A, PINTO L: Increased methyl esterification of membrane proteins in aged red-blood cells. Preferential esterification of ankyrin and band-4.1 cytoskeletal proteins. Eur J Biochem 135:25-31, 1983
25. FREITAG C, CLARKE S: Reversible methylation of cytoskeletal and membrane proteins in intact human erythrocytes. J Biol Chem 256: 6102-6108, 1981
26. ZAPPIA V, ZYDEK-CWICK CR, SCHLENK F: The specificity of S-adenosylmethionine derivatives in methyl transfer reactions. J Biol Chem 244:4499-4505, 1969
27. DELA HABA G, CANTONI GL: The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine. J Biol Chem 234:603-608, 1959
28. BARBER JR, CLARKE S: Inhibition of protein carboxyl methylation by S-adenosyl-L-homocysteine in intact erythrocytes. Physiological consequences. J Biol Chem 259:7115-7122, 1984
29. CANTONI GL, RICHARDS HH, CHIANG PK: Inhibitors of S-adenosylhomocysteine hydrolase and their role in the regulation of biological methylation, in Transmethylation, edited by USDIN E, BORCHARD RT, CREVELING CR, Amsterdam, Elsevier/North Holland, 1979, pp 155-164
30. OLIVA A, GALLETTI P, ZAPPIA V, PAIK WK, KIM S: Studies on substrate specificity of S-adenosylmethionine: Protein-carboxyl methyltransferase from calf brain. Eur J Biochem 104:595-602, 1980
31. CANTONI GL, CHIANG PK: The role of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in the control of biologic methylations, in Natural Sulfur Compounds: Novel Biochemical and Structural Aspects, edited by CAVALLINI D, GAULL GE, ZAPPIA V, New York, Plenum Press, 1980, p 67
32. STIPANUK M: Metabolism of sulfur-containing amino acids. Ann Rev Nutr 6:179-209, 1986
33. SELHUB J, MILLER JW: The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55:131-138, 1992
34. JAKUBOSKI H, GOLDMAN E: Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells. FEBS Lett 317:237-240, 1993
35. MCCULLY KS: Chemical pathology of homocysteine. I. Atherogenesis. Ann Clin Lab Sci 23:477-493, 1993
36. MCCULLY KS: Chemical pathology of homocysteine. II. Carcinogenesis and homocysteine. Thiolactone metabolism. Ann Clin Lab Sci 24:27-59, 1994
37. MCCULLY KS: Chemical pathology of homocysteine. III. Cellular function and aging. Ann Clin Lab Sci 24:134-152, 1994
38. ANDERSSON A, ISAKSSON A, HULTBERG B: Homocysteine export from erythrocytes and its implication for plasma sampling. Clin Chem 38:1311-1315, 1992
39. CLARKE R, DALY L, ROBINSON K, NAUGHTEN E, CAHALANE S, FOWLER B, GRAHAM I: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 324:1149-1155, 1991
40. STAMPFER MJ, MALINOW MR, WILLETT WC, NEWCOMER LM, UPSON B, ULLMANN D, TISHLER PV, HENNEKENS CH: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877-881, 1992
41. MALINOW MR, NIETO FJ, SZKLO M, CHAMBLESS LE, BOND G: Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The atherosclerosis risk in communities study. Circulation 87:1107-1113, 1993
42. NYGARD O, VOLLSET SE, REFSUM H, STENSVOLD I, TVERDAL A, NORDREHAUG JE, UELAND PM, KVALE G: Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 274:1526-1533, 1995
43. ROBINSON K, MAYER EL, MILLER DP, GREEN R, VAN LENTE F, GUPTA A, KOTTKE-MARCHANT K, SAVON SR, SELHUB J, NISSEN SE, KUTNER M, TOPOL EJ, JACOBSEN DW: Hyperhomocysteinemia and low pyridoxal phosphate: Common and independent reversible risk factors for coronary artery disease. Circulation 92:2825-2830, 1995
44. TSAI C, PERRELLA MA, YOSHIZUMI M, HSIEN C-M, HABE E, SCHLAGEL R, LEE M-E: Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 91:6369-6373, 1994
45. HARPEL PC, CHANG VT, BORT W: Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: A potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci USA 89:10193-10197, 1992
46. PREIBISCH G, KUFFNER, ELSTNER EF: Biochemical model reactions on the prooxidative activity of homocysteine. J Biosci 48c:58-62, 1992
47. HAJJAR KA: Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest 91:2873-2879, 1993
48. RODGERS GM, KANE WH: Activation of endogenous Factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77:1909-1916, 1986
49. HAYASHI T, HONDA G, SUZUKI K: An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood 79:2930-2936, 1992
50. OAKLEY GP: Folic acid fortification - Prevention opportunity of the decade? Irish J Med Sci 164:(S)14, 1995
51. WILCKEN DEL, GUPTA VJ, REDDY SG: Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis. Clin Sci 58:427-430, 1980
52. LAIDLAW SA, SMOLIN LA, DAVIDSON WD, KOPPLE JD: Sulfur amino acids in maintenance hemodialysis patients. Kidney Int 32(Suppl 22):S191-S196, 1987
53. CHAUVEAU P, CHADEFAUX B, COUDÉ M, AUPETIT J, HANNEDOUCHE T, KAMOUN P, JUNGERS P: Increased plasma homocysteine concentration in patients with chronic renal failure. Miner Electrol Metab 18:196-198, 1992
54. CHAUVEAU P, CHADEFAUX B, COUDÈ M, AUPETIT J, HANNEDOUCHE T, KAMOUN P, JUNGERS P: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 43(Suppl 41): S72-S77, 1993
55. PARFREY PS: Cardiac and cerebrovascular disease in chronic uremia. Am J Kid Dis 21:77-80, 1993
56. BACHMANN J, TEPEL M, RAIDT H, RIEZLER R, GRAEFE U, LANGER K, ZIDEK W: Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 6:121-125, 1995
57. GUTTORMSEN AB, SVARSTAD E, UELAND PM, REFSUM H: Elimination of homocysteine from plasma in subjects with end stage renal failure. Irish J Med Sci 164:(S)8-9, 1995
58. BOSTOM AG, BROSNAN JT, HALL B, NADEAU MR, SELHUB J: Homocysteine metabolism by the rat kidney in vivo. Irish J Med Sci 164:(S)2-3, 1995
59. BOSTOM AG, BROSNAN JT, HALL B, NADEAU MR, SELHUB J: Net uptake of plasma homocyteine by the rat kidney in vivo. Atherosclerosis 116:59-62, 1995
60. JONTOFSOHN R, TRIVISAS G, KATZ N, KLUTHE R: Amino acid content of erythrocytes in uremia. Am J Clin Nutr 31:1956-1960, 1978
61. SHAW AB: Haemolysis in chronic renal failure. Br Med J 2:213-216, 1967
62. AKMAL M, TELFER N, ANSARI AN, MASSRY SG: Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism. J Clin Invest 76:1695-1698, 1985
63. INAUEN W, STÄUBLI M, DESCOEUDRES C, GALEAZZI RL, STRAUB PW: Erythrocyte deformability in dialysed and non-dialysed uraemic patients. Eur J Clin Invest 12:173-176, 1982
64. MCGRATH LT, DOUGLAS AF, MCCLEAN E, BROWN JH, DOHERTY CC, JOHNSTON GD, POOLER G, ARCHBOLD R: Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis. Clin Chim Acta 235:179-188, 1995
65. - anion exchanger in erythrocytes of uraemic patients. Nephrol Dial Transplant 5:1018-1022, 1990
66. + pump in chronic renal failure. Am J Physiol 252:F785-F793, 1987
67. KELLY RA, CANESSA ML, STEINMAN TI, MITCH WE: Hemodialysis and red cell cation transport in uremia: Role of membrane free fatty acids. Kidney Int 35:595-603, 1989
68. CORRY DB, LEE DBM, TUEK ML: A kinetic study of cation transport in erythrocytes from uremic patients. Kidney Int 32:256-260, 1987
69. PERNA AF, INGROSSO D, GALLETTI P, ZAPPIA V, DE SANTO NG: Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure: Evidence for high levels of the natural inhibitor S-adenosylhomocysteine. J Clin Invest 91:2497-2503, 1993
70. HARAM S, CARRIERO D, SEAMAN C, PIOMELLI S: The mechanism of decline of age-dependent enzymes in the red blood cell. Enzyme 45:47-53, 1991
71. PERNA AF, INGROSSO D, DE SANTO NG, GALLETTI P, ZAPPIA V: Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney Int 47:247-253, 1995
72. INGROSSO D, D'ANGELO S, PERROTTA S, D'URZO G, IOLASCON A, PERNA AF, GALLETTI P, ZAPPIA V, MIRAGLIA DEL GIUDCE E: Cytoskeletal behaviour in spectrin and in band 3 deficient spherocytic red cells: Evidence for a differentiated splenic conditioning role. Br J Haematol 93:38-41, 1996
73. HOFFMAN RM: Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. Biochim Biophys Acta 738:49-87, 1984
74. NEWBERNE MP, ROGERS AE: Labile methyl groups and the promotion of cancer. Ann Rev Nutr 6:407-432, 1986
75. DUERRE JA, DI MARIA P, KIM S, PAIK WK: Current status of protein methylation in carcinogenesis. Crit Rev Oncol 2:97-108, 1991
76. PORT FK: Fatal neoplasms in dialysis patients: A population-based study. Am J Kid Dis 24:119-125, 1989
77. ISEKI K, OSAWA A, FUKIYAMA K: Evidence for increased cancer deaths in chronic dialysis patients. Am J Kid Dis 22:308-313, 1993
78. MCFADDEN RG, FRAHER LG: Inhibitors of membrane transmethylation reactions prevent the lymphocyte chemokinetic response, Immunol Lett 26:211-215, 1990
79. PIKE MC, DE MEESTER CA: Inhibition of phosphoinositide metabolism in human polymorphonuclear leucocytes by S-adenosylhomocysteine. J Biol Chem 263:3592-3599, 1988
80. FADDA GZ, HAJJAR SM, PERNA AF, ZHOU X-J, LIPSON LG, MASSRY SG: On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 87:255-261, 1991
81. BEST L, LEBRUN P, SACEDA M, GARCIA-MORALES P, HUBINOT C, JUVENT M, HERCHUELZ A, MALAISSE-LAGAE F, VALVERDE I, MALAISSE WJ: Impairment of insulin release by methylation inhibitors. Biochem Pharmacol 33:2033-2039, 1984
82. AHL R: Effect of inhibitors of methylation on early and late interferon synthesis in bovine kidney cell coltures. J Interferon Res 1:203-218, 1981
83. LAMPERI S, CAROZZI S: γ-Interferon as an in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continous ambulatory peritoneal dialysis, in Prevention of Progressive Uremia, edited by FRIEDMAN EA, BEYER M, DE SANTO NG, GIORDANO C, New York, Field and Wood, 1989, pp 129-133
84. HEILBREDER E, SCHAFFERHANS K, GÖTZ R, BAUSEWEIN K, HEIDLAND A: Plasma catecholamines in renal failure, in Hormonal and Metabolic Derangements in Renal Failure, edited by HEIDLAND A, QUELLHORST E, HEILBREDER E, RITZ E, MASSRY SG, Basel, Karger, 1986, pp 14-27
85. SMOGORZEWSKI M, CAMPESE VM, MASSRY SG: Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure. Kidney Int 36:458-465, 1989
86. FULLER RW: Inhibitors of norepinephrine N-methyltransferase, in Trsnsmethylation, edited by USDIN E, BORCHARD RT, CREVELING CR, Amsterdam, Elsevier/North Holland, 1979, pp 251-259
87. SAMET MK, RUTLEDGE CO: Inhibition of norepinephrine uptake by inhibitors of methylation, in Biochemistry of S-Adenosylmethionine and Related Compounds, edited by USDIN E, BORCHARDT RT, CREVELING CR, London, MacMillan Press, 1982, pp 195-198
88. DUCH DS, BOWERS S, EDELSTEIN M, NICHOL CA: Histamine: Elevation of brain levels by inhibition of histamine N-methyl transferase, in Transmethylation, edited by USDIN E, BORCHARD RT, CREVELING CR, Amsterdam, Elsevier/North Holland, 1979, pp 287-295
89. SCHMID G, PRZUNTEK H, FRICKE L, HEIDLAND A, HEMPEL K: Increased histidine and histamine content in the brain of chronic uremic rats. Am J Clin Nutr 31:1665-1668, 1978
90. ELLIOTT GR, BARCHAS JD: The transmethylation hypothesis of schizophrenia, in Transmethylation, edited by USDIN E, BORCHARD RT, CREVELING CR, Amsterdam, Elsevier/North Holland, 1979, pp 307-318
91. BIASIOLI S, FERIANI M, CHIARAMONTE S, PORENA P, PETROSINO L, ZAMBELLO A, CESARO A, PRADELLA M, CAVALLINI L: The serotoninergic system in uremia: Relationship to hormonal status, in Prevention of Progressive Uremia, edited by FRIEDMAN EA, BEYER M, DE SANTO NG, GIORDANO C, New York, Field and Wood, 1989, pp 79-82
92. WILCKEN DEL, DUDMAN NPB, TYRRELL PA, ROBERTSON MR: Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular disease. Metabolism 37:697-701, 1988
93. ARNADOTTIR M, BRATTSTROM LA, SIMONSEN O, THYSELL H, HULTBERG B, ANDERSSON A, NILSSON-EHLE P: The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 40:236-240, 1993
94. BOSTOM AG, SHEMIN D, LAPANE KL, HUME AL, YOBURN D, NADEAU MR, BENDICH A, SELHUB J, ROSENBERG IH: High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 49:147-152, 1996